About IGF-1 LR3
A long-acting analogue of IGF-1 with 83 amino acids, studied for tissue growth, muscle protein synthesis, and cellular recovery.
Research dose ranges
- Dose: 20–100 mcg per administration
- Frequency: 1× per day
- Route: subcutaneous
- Half-life: ~25 hours
- Cycle: 4 weeks on / 4 off
Research protocols report doses of 20–100 mcg subcutaneously or intramuscularly once daily, typically post-exercise in muscle-focused studies. Short cycles (4 weeks on, 4 weeks off) are common due to concerns about receptor desensitization.
Storage
Store lyophilized vials at -20°C for long-term stability; short-term storage at 2–8°C is acceptable. Reconstituted solution should be refrigerated and used within 14–21 days.